Catalogo dei prodotti della ricerca

FRANCIA, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.734
EU - Europa 1.338
AS - Asia 747
SA - Sud America 31
AF - Africa 29
OC - Oceania 8
Totale 5.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.709
IT - Italia 401
SG - Singapore 369
DE - Germania 260
IN - India 189
UA - Ucraina 177
SE - Svezia 129
CN - Cina 118
FI - Finlandia 107
IE - Irlanda 55
ID - Indonesia 33
RU - Federazione Russa 32
BG - Bulgaria 31
GB - Regno Unito 31
AT - Austria 28
TG - Togo 28
AR - Argentina 25
FR - Francia 22
NL - Olanda 18
BE - Belgio 15
CA - Canada 15
RO - Romania 14
HK - Hong Kong 9
MX - Messico 9
AU - Australia 7
TR - Turchia 7
RS - Serbia 5
BR - Brasile 4
ES - Italia 3
IR - Iran 3
MY - Malesia 3
PK - Pakistan 3
TW - Taiwan 3
JO - Giordania 2
PL - Polonia 2
AM - Armenia 1
BD - Bangladesh 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
JP - Giappone 1
KR - Corea 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
VE - Venezuela 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 5.887
Salva come PNG Salva come JPEG
Città #
Fairfield 576
Singapore 292
Woodbridge 292
Ashburn 252
Houston 239
Seattle 231
Chandler 224
Ann Arbor 201
Cambridge 199
Wilmington 183
Rome 156
Santa Clara 123
Princeton 107
Plano 89
San Paolo di Civitate 82
Jacksonville 72
Lawrence 66
Beijing 64
Millbury 53
Boston 50
Dearborn 47
Dublin 42
San Diego 38
New York 33
Jakarta 31
Sofia 31
Andover 29
Lomé 28
Boardman 27
Norwalk 26
Federal 23
Vienna 22
Helsinki 19
Moscow 18
Milan 16
Brussels 15
Fremont 14
Frankfurt am Main 12
Lappeenranta 11
Naples 11
Falkenstein 10
Falls Church 10
Bühl 9
Toronto 9
Amsterdam 7
Des Moines 7
Hong Kong 7
Munich 7
Phoenix 7
Kunming 6
Pune 6
Hefei 5
Jinan 5
Marcq-en-baroeul 5
Ottawa 5
Istanbul 4
San Mateo 4
Wuhan 4
Bergamo 3
Bologna 3
Buffalo 3
Catania 3
Florence 3
Lahore 3
Lancenigo-Villorba 3
Los Angeles 3
Menlo Park 3
Ningbo 3
Oxford 3
São Paulo 3
Brooklyn 2
Camparada 2
Cantalupo in Sabina 2
Central 2
Chengdu 2
Chongqing 2
Genoa 2
Hostalric 2
Indiana 2
Keelung 2
Klaten 2
Krakow 2
Las Vegas 2
Laurel 2
Leawood 2
Livorno 2
London 2
Macerata 2
Mannheim 2
Mexico City 2
Nanchang 2
Pabillonis 2
Palermo 2
Parma 2
Provo 2
Reggio Emilia 2
Rho 2
Rieti 2
Romainville 2
Siracusa 2
Totale 4.257
Salva come PNG Salva come JPEG
Nome #
Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists 116
Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy 110
A next-generation sequencing approach to identify gene mutations in early-and late-onset hypertrophic cardiomyopathy patients of an Italian cohort 105
Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin 102
Prediction of Long-Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15-Year Prospective Follow-Up Study 99
Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy 95
Arrhythmia Detection in Single and Dual Chamber Implantable Cardioverter Defibrillators: The More Leads, the Better? 94
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy 93
null 91
Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter-Defibrillator in Patients with Hypertrophic Cardiomyopathy. 91
P-Wave Duration in Lead aVR and the Risk of Atrial Fibrillation in Hypertension. 90
RyR2 common gene variant G1886S and the risk of ventricular arrhythmias in ICD patients with heart failure. 87
Distinguishing hypertension from hypertrophic cardiomyopathy as a cause of left ventricular hypertrophy 86
Oxidative stress and cardiovascular disease 83
Time to therapy delivery and effectiveness of subcutaneous implantable cardioverter-defibrillator 83
Atrial natriuretic peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation 83
Low-dose angiotensin receptor blockers as an alternative to ACE-inhibitors increase the risk of appropriate ICD interventions in heart failure 82
Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter? 81
Anti-Aging Medicine: Molecular Basis for Endothelial Cell-Targeted Strategies - A Mini-Review 79
A novel electrocardiographic T-Wave measurement (Tp-Te Interval) as a predictor of heart abnormalities in hypertension: a new opportunity for first-line electrocardiographic evaluation 76
Outcomes of early invasive treatment strategy in elderly patients with non-ST elevation acute coronary syndromes 76
p66(Shc) protein, oxidative stress, and cardiovascular complications of diabetes: the missing link. 75
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome 75
Osteopontin and Galectin-3 Predict the Risk of Ventricular Tachycardia and Fibrillation in Heart Failure Patients with Implantable Defibrillators. 74
Tp-Te interval predicts heart rate reduction after fingolimod administration in patients with multiple sclerosis 74
Left bundle branch block: pathophysiology, prognosis and clinical management 72
Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool 72
Calcium Channel Blockers and Hypertension. 71
Diabetes Mellitus and Metabolic Syndrome 70
Electrophysiological study and catheter ablation of a Mahaim fibre located at the mitral annulus-aorta junction 69
Vascular senescence at the crossroad between oxidative stress and nitric oxide pathways: Disclosing the secret of dorian gray 67
Safety and efficacy of anti-tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD 67
Deletion of p66shc gene protects against age-related endothelial dysfunction. 67
Plasma osteopontin reveals left ventricular reverse remodelling following cardiac resynchronization therapy in heart failure 65
Clinical Course and Quality of Life in High-Risk Patients with Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators 65
Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man. 65
Electrocardiographic evolution in patients with hypertrophic cardiomyopathy who develop a left ventricular apical aneurysm 65
Circadian periodicity of the daily human heart rate variability chaos: further demonstration trough chronobiologic approach to the alpha exponent 64
The apelin/APJ system. From vascular biology to heart failure 63
Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator 63
Autonomic cardiovascular control and cardiac arrhythmia in two pregnant women with hypertrophic cardiomyopathy: Insights from ICD monitoring 63
The subcutaneous implantable cardioverter-defibrillator. Current trends in clinical practice between guidelines and technology progress 63
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge 63
Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. 62
Synergistic effects of cardiac resynchronization therapy and drug up-titration in heart failure. is this enough? 61
Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy. results from an Italian multicenter registry 61
Ventricular fibrillation undersensing due to air entrapment in a patient implanted with a subcutaneous cardioverter defibrillator 61
Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. 59
Impact of hypertension on global cardiovascular risk stratification: analysis of a large cohort of outpatient population in Italy 59
Gene variants of calcium handling proteins as a determinant of ventricular arrhythmias in ICD recipients with heart failure 58
Idiopathic dilated cardiomyopathy associated with coeliac disease: the effect of a gluten-free diet on cardiac performance 55
Do COX-2 inhibitors really prevent hypertension and proteinuria? Another brick in the wall for the COX-2 inhibition and cardiovascular disease controversy 54
Analysis of the chaotic component of the sinusal R-R intervals as a tool for detecting a silent cardiac dysautonomia in type 2 diabetes mellitus 54
Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition 54
Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey. 53
Diabetes Mellitus and Metabolic Syndrome 52
Nitric oxide release is impaired in hypertensives with familial history of stroke 51
Common genetic variants in selected Ca2+ signaling genes and the risk of appropriate ICD interventions in patients with heart failure 50
Calcium handling proteins gene variants and the risk of ventricular arrhythmias in ICD recipients with heart failure: focus on extremely opposing phenotypes 50
Subcutaneous implantable cardioverter defibrillator in cardiomyopathies and channelopathies 49
Calcium Handling Proteins Common Gene Variants And Risk Of Ventricular Arrhythmias In ICD Recipients With Heart Failure. 49
Atrial fibrillation detection by multi-lead ECG processing at the edge 48
Subcutaneous implantable cardioverter defibrillator implantation. An analysis of Italian clinical practice and its evolution 47
New oral anticoagulants in non-valvular atrial fibrillation. 46
Effect of gluten-free diet on cardiac performance in patients with idiopathic dilated cardiomyopathy and celiac disease . 45
Extracellular matrix remodelling in myocardial hypertrophy and failure: focus on osteopontin 43
Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique 43
Role of induced pluripotent stem cells in diagnostic cardiology 43
Repolarization abnormalities and arrhythmogenesis in hypertrophic myocardium 42
Deletion of p66Shc gene restores endothelial function in a mouse model of obesity and insulin resistance. 42
Multi-modality imaging approach in a challenging case of surgically corrected partial anomalous pulmonary venous return and atrial tachycardia treated with radiofrequency ablation 42
L’ablazione della fibrillazione atriale come terapia di scelta? 41
Coeliac disease and dilated cardiomyopathy: a new association with potential therapeutic implications 40
Clinical Course of Pregnancy and Long-Term Follow-Up After Delivery in Hypertrophic Cardiomyopathy 39
Genetic deletion of the p66Shc adaptor protein protects against age-related cardiac arrhythmias. 38
Prevention of sudden cardiac death: focus on the subcutaneous implantable cardioverter-defibrillator 37
Personalized pulmonary vein antrum isolation guided by left atrial wall thickness for persistent atrial fibrillation 36
Il Trattamento dell’Insufficienza Cardiaca nelle Nuove Linee Guida ESC: dal 2005 al 2008, con Qualche Novità 36
Identification and Elimination of Ancillary Arrhythmias 36
DIZIONARIO DI MEDICINA TRECCANI 35
Substrates of scar-related ventricular arrhythmia in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study 35
La resincronizzazione cardiaca nelle classi NYHA I e II 34
Is a Reduced Entropy in Heart Rate Variability an Early Finding of Silent Cardiac Neurovegetative Dysautonomia in Type 2 Diabetes Mellitus? 31
[The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use]. 31
Pregnancy and heart rate variability in women affected by type1 diabetes mellitus with or without autonomic neuropathy. 30
Prognostic implications of non-sustained VT morphology in high-risk patients with HCM 30
Is reduced entropy in hearth rate variability an early finding of silent cardiac neurovetative disautonomia in type 2 diabetes mellitus? 29
Cardiologia: lo stato dell'arte 28
Il Monitoraggio Continuo dell’Impedenza Intratoracica nella Gestione Ambulatoriale del Paziente con Insufficienza Cardiaca 27
L’associazione tra morbo celiaco e cardiomiopatia dilatativi idiopatica: effetti della dieta gluten –free 27
ARITMIE 27
The effects of gender on electrical therapies for the heart: procedural considerations, results and complications. A report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC) 27
Rate o Rhythm Control? La Gestione della Fibrillazione Atriale nell’Insufficienza Cardiaca 26
Viewpoint: Climbing the academic ladder in Italy. 26
The loss of entropy circadian rhythm in sinusal R-R intervals of type 1 diabetic pregnant women suggests an indeterministic chaos in cardiac pacing (minimum delirium cordis syndrome). A newly identifiable type of silent cardiac dysautonomia? 26
Deficit di carnitina in pazienti affetti da morbo celiaco e cardiomiopatia dilatativia idiopatica: effetti della dieta priva di glutine. 24
Clinical impact of aging on outcomes of cardioneuroablation for reflex syncope or functional bradycardia. Results from the cardionEuroabLation: patiEnt selection, imaGe integrAtioN and outComEs. The ELEGANCE multicenter study 22
MUSE. MUlti-lead Sub-beat ECG for remote AI based atrial fibrillation detection 22
Deficit di carnitina in pazienti affetti da morbo celiaco e cardiomiopatia dilatativa idiopatica:effetti della dieta priva di glutine 22
Prognostic implications of different clinical profiles in hypertrophic cardiomyopathy 22
Totale 5.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.507
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020666 0 0 0 0 0 0 166 154 136 114 54 42
2020/2021440 52 63 12 23 9 32 5 35 50 88 54 17
2021/20221.040 15 68 96 57 142 23 22 104 91 74 168 180
2022/20231.066 178 203 31 91 110 92 22 65 128 29 49 68
2023/2024589 31 72 28 62 45 88 21 35 14 78 48 67
2024/2025678 31 104 140 109 143 110 41 0 0 0 0 0
Totale 6.245